↓ Skip to main content

Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension

Overview of attention for article published in JAMA Internal Medicine, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
155 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension
Published in
JAMA Internal Medicine, December 2018
DOI 10.1001/jamainternmed.2018.4684
Pubmed ID
Authors

James P. Sheppard, Sarah Stevens, Richard Stevens, Una Martin, Jonathan Mant, F. D. Richard Hobbs, Richard J. McManus

Twitter Demographics

The data shown below were collected from the profiles of 812 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 155 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 155 100%

Demographic breakdown

Readers by professional status Count As %
Other 27 17%
Researcher 23 15%
Student > Postgraduate 17 11%
Student > Ph. D. Student 17 11%
Professor > Associate Professor 11 7%
Other 41 26%
Unknown 19 12%
Readers by discipline Count As %
Medicine and Dentistry 89 57%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Nursing and Health Professions 7 5%
Biochemistry, Genetics and Molecular Biology 3 2%
Psychology 3 2%
Other 11 7%
Unknown 34 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 623. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2020.
All research outputs
#16,133
of 16,087,154 outputs
Outputs from JAMA Internal Medicine
#205
of 4,194 outputs
Outputs of similar age
#626
of 324,868 outputs
Outputs of similar age from JAMA Internal Medicine
#11
of 123 outputs
Altmetric has tracked 16,087,154 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,194 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 140.3. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,868 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.